These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11901939)

  • 1. [Reduced risk of stroke recurrence due to hypotensive medication, irrespective of the initial blood pressure].
    Lenders JW; Thien T
    Ned Tijdschr Geneeskd; 2002 Mar; 146(9):398-9. PubMed ID: 11901939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee.
    J Hypertens; 1999 Nov; 17(11):1647-55. PubMed ID: 10608480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PROGRESS--perindopril protection against recurrent stroke study: status in July 1996. PROGRESS Management Committee.
    J Hypertens Suppl; 1996 Dec; 14(6):S47-51. PubMed ID: 9023716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.
    PROGRESS Collaborative Group
    Lancet; 2001 Sep; 358(9287):1033-41. PubMed ID: 11589932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee.
    Chalmers J; Neal B; MacMahon S;
    J Hypertens Suppl; 2000 May; 18(1):S13-9. PubMed ID: 10939785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertension in the acute phase and in the secondary prevention of stroke].
    Arquizan C
    Rev Prat; 2004 Mar; 54(6):637-40. PubMed ID: 15222615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke secondary prevention and blood pressure reduction: an observational study of the use of PROGRESS therapy.
    Bugnicourt JM; Chillon JM; Canaple S; Lamy C; Godefroy O
    Fundam Clin Pharmacol; 2008 Apr; 22(2):217-22. PubMed ID: 18353116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cerebrovascular sequelae of hypertension].
    Schrader J; Lüders S; Diener HC
    Herz; 2003 Dec; 28(8):707-16. PubMed ID: 14689105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PROGRESS: Perindopril pROtection aGainst REcurrent Stroke Study: status in March 1997. PROGRESS Management Committee.
    J Hum Hypertens; 1998 Sep; 12(9):627-9. PubMed ID: 9783492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of diuretics in combination with perindopril in hypertensive stroke patients: Results of the Japan Perindopril and Diuretics on Cerebrovascular Disease Study (J-PADOC).
    Hasegawa Y; Shimada K; Yamaguchi T
    Blood Press Suppl; 2010 Feb; 1():10-6. PubMed ID: 20175714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH
    Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second Australian National Blood Pressure Study (ANBP2). Australian Comparative Outcome Trial of ACE inhibitor- and diuretic-based treatment of hypertension in the elderly. Management Committee on behalf of the High Blood Pressure Research Council of Australia.
    Wing LM; Reid CM; Ryan P; Beilin LJ; Brown MA; Jennings GL; Johnston CI; McNeil JJ; Marley JE; Morgan TO; Shaw J; Steven ID; West MJ
    Clin Exp Hypertens; 1997; 19(5-6):779-91. PubMed ID: 9247755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of blood pressure lowering treatment on stroke recurrence in patients with cerebrovascular diseases-a large-scale, randomized, placebo controlled trial].
    Liu LS; Gong LS; Wang W;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jul; 33(7):613-7. PubMed ID: 16080808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial.
    Chapman N; Huxley R; Anderson C; Bousser MG; Chalmers J; Colman S; Davis S; Donnan G; MacMahon S; Neal B; Warlow C; Woodward M;
    Stroke; 2004 Jan; 35(1):116-21. PubMed ID: 14671247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secondary prevention of stroke through arterial blood pressure reduction].
    Mancia G; Grassi G
    Cardiologia; 1997 Jul; 42(7):715-9. PubMed ID: 9340173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New concepts in blood pressure-lowering management in diabetic patients: the case for early ACE inhibitor combination therapy with diuretics.
    Mogensen CE
    J Hum Hypertens; 2005 Jun; 19 Suppl 1():S15-20. PubMed ID: 16075028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global impact of stroke.
    Chalmers J
    Heart Dis; 2000; 2(2):S13-7. PubMed ID: 11728258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.